Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

Dexcom has invested $75 million into Oura, which values Oura at $5 billion. And the details of the deal could have a ...

Finland in 2013, makes a smart ring that helps customers track sleep, activity, stress and heart health among other features. Dexcom makes continuous glucose monitoring devices, including a ...

Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the company's products to ...

The news comes just weeks after the launch of Oura’s latest product, the Oura Ring 4. Dexcom’s continuous glucose monitoring ...

Dexcom launching a OTC wearable product that makes glucose monitoring ... About 23% of Oura members have worn a CGM. "That ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...